The evolution of synthetic drugs has hit a dangerous new milestone.
A group of substances called orphines is starting to show up in illegal markets, and it’s creating a new challenge for public health safety.
Unlike earlier waves of the opioid crisis, these drugs can’t be detected with standard screening tests. They’re also said to be 10 times more dangerous than fentanyl.
While orphines aren’t as common as fentanyl right now, their numbers are increasing rapidly. As reported recently by The New York Times, they have been detected in 14 states as of last month, mainly in the South and Midwest. Law enforcement and public health officials are striving to understand how long-lasting this threat might be.
This lack of visibility, combined with this drug’s extreme potency, means that users, healthcare providers and families are facing a hidden hazard so perilous, it demands action and new testing methods immediately.
Here’s everything you need to know about orphines, according to the experts.
What are orphines?
According to the United Nations Office on Drugs and Crime,
Orphines, a potent class of opioids developed by Dr. Paul Janssen in the 1960s, were originally intended to provide quick and effective pain relief for surgical procedures. During his research, Dr. Janssen and his team inadvertently created fentanyl, another well-known opioid.
However, they soon discovered that orphines came with alarming side effects, including severe breathing issues and a high potential for addiction. As a result, studies on these substances were halted just a few years after they began.
What’s particularly striking is that orphines are reported to be ten times stronger than fentanyl, even in minuscule amounts – think the size of a few grains of sand. This remarkable potency poses an incredible risk because exposure can lead to rapid and deadly consequences, such as sudden collapse, respiratory failure and stiff chest muscles. In some cases, the typical signs of an overdose, like the infamous “foam cone” (the frothy discharge from the nose and mouth), may not even have time to manifest before tragedy strikes.
Still, according to the medical journal Anesthesiology, published by the American Society of Anesthesiologists, people who take too much opioid medication can be helped with naloxone, a drug that counteracts the effects of opioids. However, it might require multiple doses of naloxone to bring someone back to consciousness, which is more than the one or two doses typically needed for fentanyl.
Why did orphines begin to show up in the United States?
A report from The Times explains that provinces of orphines began showing up in the street drug market after global efforts to crack down on fentanyl. Following the Drug Enforcement Administration’s temporary ban on all fentanyl-related substances, or analogs, in 2018, there was a notable shift in the landscape of synthetic opioids.
An article published in The Journal of Medicinal Chemistry that same year discussed the challenges of developing opioids without harmful side effects and specifically warned about the dangers of orphines. This research seems to have influenced some chemists, leading them to create orphines in an effort to sidestep international drug regulations.
By 2019, the first orphine, known as brorphine, began appearing in Europe. Simultaneously, a new group of synthetic opioids called nitazenes was also surfacing in both Europe and the United States, raising alarms among law enforcement and public health officials. In a move to combat this issue, China, a key supplier of the chemicals needed to produce nitazenes, imposed a ban on them in July 2025.
Nitazenes started to disappear, but just a few months later, orphines appeared in the illegal drug market in the United States.
In what forms are orphines sold?
The most common orphine is a version called cychlorphine (also known as N-propionitrile chlorphine). This substance is often found in fake pills or as a powder, mixed with fentanyl to increase its effects. Users may overdose or even die because they are unaware that the drug they intended to take – like methamphetamine – has been mixed with cychlorphine.
Cychlorphine is relatively new and hard to detect, leading researchers to believe it is frequently shipped through international mail. Besides the United States, it has also been found in Estonia, Latvia, Lithuania, France and Germany, where it is inexpensive and widely available, earning the nickname “poor man’s fentanyl.
The Final Takeaway
As the opioid crisis drags on, it’s shining a spotlight on how substance abuse is changing. It’s also increasingly evident that we need to be more aware and take action.
Cyclophene may be a less familiar drug right now, it is a stark reminder that people are always looking for new ways to cope, often choosing risky alternatives as the stigma around regular opioids increases.
This change makes addiction more complex. And it requires our communities and healthcare providers to take a greater proactive stance. By keeping up with these shifts and pushing for better support systems, we can more effectively tackle the root issues of substance abuse and help those affected find healthier ways to recover.
